A market access plan is more useful when regulatory, commercial, supply, and clinical questions are considered together. A registration pathway on its own does not define how a product will reach hospitals or be supported in practice.
A registration pathway on its own does not define how a product will reach hospitals or be supported in practice.
MEDEMBARK editorial team
Start with the product and intended market
- Define intended use, configurations, accessories, and target clinical teams.
- Review the manufacturer document set before committing to a timeline.
- Map procurement, distribution, training, and support requirements.
- Identify the hospitals, specialties, and use settings that shape demand and service expectations.
- Agree which assumptions need evidence before the launch plan can advance.
Build around four connected workstreams
Each workstream has a different owner and vocabulary, but the same product identity, claims, configurations, timing, and evidence should connect them. A decision in one stream can move the others.
| Workstream | Question to resolve | Useful output |
|---|---|---|
| Regulatory | What route, class, evidence, localization, and approval conditions apply? | A defensible pathway, dossier plan, and decision calendar. |
| Supply | How will approved configurations be forecast, imported, stored, delivered, and replenished? | A controlled supply model with visible lead times and handoffs. |
| Clinical education | Who needs approved product familiarisation, when, and in what format? | A responsible training plan tied to launch readiness and support capacity. |
| Commercial and procurement | Which institutions, buying processes, budgets, and service expectations shape adoption? | A realistic opportunity map and engagement sequence. |
Connect the milestones—not just the dates
Registration, translation, import preparation, forecasting, launch materials, and clinical education often depend on one another. A shared milestone plan makes those dependencies visible and identifies the decisions that can safely run in parallel.
- Foundation
Freeze product scope and intended use
Align the exact configurations, accessories, claims, users, and manufacturing identity across every workstream.
- Evidence
Choose the pathway and close document gaps
Confirm class and route, review the manufacturer file, and assign localization and evidence owners.
- Readiness
Design supply and support capacity
Model lead times, storage, delivery, forecasting, training resources, and post-launch issue handling.
- Engagement
Sequence institutions and clinical teams
Coordinate procurement context, approved materials, demonstrations, education, and local feedback.
- Launch
Advance only when the dependencies agree
Reconfirm approvals, inventory, materials, training, ownership, and escalation paths before execution.
Registration-only plan or integrated plan?
| Planning lens | Registration-only | Integrated market access |
|---|---|---|
| Primary question | How do we obtain the certificate? | How does the approved product reach and support its intended users? |
| Dependencies | Often tracked after submission. | Mapped early across evidence, supply, procurement, and education. |
| Launch date | May follow the regulatory estimate alone. | Reflects approval plus inventory, materials, training, and operational readiness. |
| Feedback | Usually arrives late. | Captured deliberately and routed to the correct owner without changing approved claims. |
Keep assumptions explicit
Regulatory requirements and market conditions can change. Project scope, responsibilities, and timing should be reconfirmed after document review and at important decision points.
Use the wider MEDEMBARK planning resources
- Compare registration routes and timelinesStart with class, pathway, review clock, and recognition eligibility.
- Build the registration document mapReview the universal dossier core and product-triggered evidence modules.
- Explore distribution solutionsSee how regulatory, commercial, logistics, and clinical support connect.
- Discuss a market access planShare the product scope, current approvals, and intended Uzbekistan timeline.
